U.K. mulls R&D tax credits for midsize biotechs

12/3/2004 | Reuters

The U.K.'s chancellor of the exchequer says he intends to review a tax credit given to medium-sized biotech and drug companies for research and development with an eye to increasing them as a way to encourage the industry. Gordon Brown also said he would end tax barriers that block spin-off companies created by universities. The drug industry applauded the promised move.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
PacificSource
Boise, ID